ACAP Webinar: Thursday, July 24th | 2:00PM EST

July 9, 2025

medicaid

As GLP-1 medications like Ozempic, Wegovy and Zepbound surge in popularity for treating diabetes and obesity, Medicaid programs across the U.S. are grappling with unprecedented financial and policy challenges.  With patients paying upwards of $11,000 annually for a year supply, and Medicaid spending on these drugs skyrocketing from $577 million in 2019 to nearly $4 billion in 2023, health plans are under immense pressure to balance access, equity and sustainability.

Join Evernorth’s panel of experts from Express Scripts Pharmacy Benefit Services for a discussion on key topics including GLP-1 utilization trends, state-by-state insights, ROI and value assessment and formulary management strategies. REGISTER NOW!

legislation

Virginia and Hawaii Introduce PDAB Legislation

The Virginia Senate introduced a bill to establish a Prescription Drug Affordability Board (PDAB) to review drugs with a wholesale acquisition cost (WAC) of $60,000 or more per year or a WAC increase of $3,000 or more in any 12-month period. For drugs deemed to cause an affordability challenge, the legislation authorizes the PDAB to […]
read more >

February 12, 2026

EGWP marketplace medicaid Medicare

Solutions

AHIP Shares Update on Plan Progress to Simplify Prior Authorization

AHIP shared progress on the voluntary, multi-year commitments made by AHIP, BCBSA, and leading health plans (including Cigna Healthcare) to streamline and simplify prior authorization. Health plans serving nearly 270 million Americans are participating in this initiative. The 2026 commitments took effect on Jan. 1 and include: reducing the scope of claims subject to prior […]
read more >

February 12, 2026

EGWP marketplace medicaid Medicare

legislation

DOL Issues Proposed Rule on Improving Transparency into PBM Fees

Pursuant to President Trump’s Executive Order “Lowering Drug Prices by Once Again Putting Americans First,” the Department of Labor’s (DOL’s) Employee Benefits Security Administration (EBSA) issued a proposed rule that would require providers of PBM services and affiliated entities of brokerage and consulting services to disclose direct and indirect compensation to their self-funded ERISA fiduciary […]
read more >

February 12, 2026

EGWP marketplace medicaid Medicare

You may also like